Healthcare
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
BURLINGTON, Mass., July 29, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference.
About this update from 908 Devices Inc.
BURLINGTON, Mass., July 29, 2026 --( BUSINESS WIRE )--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. 908 Devices' management is scheduled to present on Wednesday, August 12 at 12:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at: www.908devices.com . About 908 Devices 908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company's devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20260729984797/en/ Contacts IR & Media Barbara Russo [email protected]